Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

News | March 09, 2020

Fish & Richardson Named Most Active Law Firm at Patent Trial and Appeal Board for Fourth Consecutive Year

Blog | March 05, 2020

EDTX Monthly Wrap-Up: February 2020

Blog | March 04, 2020

Legal Alert: EU Unified Patent Court and Unitary Patent Update

News | March 03, 2020

Fish & Richardson Named Top Trademark Law Firm for 10th Straight Year by World Trademark Review

Event | March 03, 2020

World Trademark Review: Managing Trademark Assets (MTA) USA 2020

Event | February 28, 2020

USD School of Law 2020 5G Conference

News | February 24, 2020

Fish & Richardson Names John Adkisson as President-elect and CEO

Event | February 24, 2020

C5's Annual Pharma and Biotech Patent Litigation Conference

Webinar | February 20, 2020

Section 101: Cert. Denied...Now What?

News | February 18, 2020

Fish & Richardson Wins Over $31 Million for Wasica and BlueArc in Long-Running Patent Dispute

Event | February 13, 2020

2020 National Bar Association 33rd Annual Corporate Counsel Conference (NBA-CLS)

News | February 11, 2020

Fish Named Law360 Life Sciences Practice Group of the Year